In vitro anti-proliferative activities of ellagic acid

被引:255
作者
Losso, JN [1 ]
Bansode, RR
Trappey, A
Bawadi, HA
Truax, R
机构
[1] Louisiana State Univ, Ctr Agr, Dept Food Sci, Baton Rouge, LA 70803 USA
[2] Louisiana State Univ, Ctr Agr, Sch Human Ecol, Baton Rouge, LA 70803 USA
[3] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA
关键词
ellagic acid; angiogenesis; human lung fibroblast cells; Caco-2; MCF-7; Hs; 578T; DU 145 cancer cells; HUVEC; metalloproteinase-2 (MMP-2); metalloproteinase-9 (MMP-9);
D O I
10.1016/j.jnutbio.2004.06.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential cytotoxic and anti-proliferative activities of ellagic acid (a naturally occurring bioactive compound in berries, grapes, and nuts) was evaluated using human umbilical vein endothelial cells (HUVEC), normal human lung fibroblast cells HEL 299, Caco-2 colon, MCF-7 breast, Hs 578T breast, and DU 145 human prostatic cancer cells. Ellagic acid at concentration in the range 10-100 mumol/L did not affect the viability of normal fibroblast cells during a 24-hour incubation. An increase in adenosine triphosphate (ATP) bioluminescence of approximately 18-21% was observed in normal cells incubated with ellagic acid. In contrast, ellagic acid at 1-100 mumol/L dose-dependently inhibited HUVEC tube formation and proliferation on a reconstituted extracellular matrix and showed strong anti-proliferative activity against the colon, breast, and prostatic cancer cell lines investigated. The most sensitive cells were the Caco-2, and the most resistant were the breast cancer cells. Ellagic acid induced cancer cell death by apoptosis as shown by the microscopic examination of cell gross morphology. Ellagic acid induced reduced cancer cell viability as shown by decreased ATP levels of the cancer cells. After 24 hours incubation of 100 mumol/L of ellagic acid with Caco-2, MCF-7, Hs 578T, and DU 145 cancer cells, ellagic acid suppressed fetal bovine serum (FBS) stimulation of cell migration. The apoptosis induction was accompanied by a decreased in the levels of pro-matrix metalloproteinase-2 (pro-MMP-2 or gelatinase A), pro-matrix metalloproteinase-9 (pro-MMP-9 or gelatinase 13), and vascular endothelial growth factor (VEGF(165)) in conditioned media. The results suggest that ellagic acid expressed a selective cytotoxicity and anti-proliferative activity, and induced apoptosis in Caco-2, MCF-7, Hs 578T, and DU 145 cancer cells without any toxic effect on the viability of normal human lung fibroblast cells. It was also observed that the mechanism of apoptosis induction in ellagic acid-treated cancer cells was associated with decreased ATP production, which is crucial for the viability of cancer cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:672 / 678
页数:7
相关论文
共 26 条
[1]   Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay [J].
Bruggisser, R ;
von Daeniken, K ;
Jundt, G ;
Schaffner, W ;
Tullberg-Reinert, H .
PLANTA MEDICA, 2002, 68 (05) :445-448
[2]   Evaluation of copper chelation agents as anti-angiogenic therapy [J].
Camphausen, K ;
Sproull, M ;
Tantama, S ;
Sankineni, S ;
Scott, T ;
Ménard, C ;
Coleman, CN ;
Brechbiel, MW .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (19) :4287-4293
[3]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[4]   Vascular endothelial growth factor and p53 expressions in liver and abdominal metastases from colon cancer [J].
Cascinu, S ;
Graziano, F ;
Catalano, V ;
Barni, S ;
Giordani, P ;
Baldelli, AM ;
Staccioli, MP ;
Rossi, C ;
Brenna, A ;
Valenti, A ;
Muretto, P ;
Catalano, G .
TUMOR BIOLOGY, 2003, 24 (02) :77-81
[5]   THE USE OF ATP BIOLUMINESCENCE AS A MEASURE OF CELL-PROLIFERATION AND CYTOTOXICITY [J].
CROUCH, SPM ;
KOZLOWSKI, R ;
SLATER, KJ ;
FLETCHER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) :81-88
[6]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[7]   Circulating VEGF levels in the serum of gastric cancer patients - Correlation with pathological variables, patient survival, and tumor surgery [J].
Karayiannakis, AJ ;
Syrigos, KN ;
Polychronidis, A ;
Zbar, A ;
Kouraklis, G ;
Simopoulos, C ;
Karatzas, G .
ANNALS OF SURGERY, 2002, 236 (01) :37-42
[8]   Clinical translation of angiogenesis inhibitors [J].
Kerbel, R ;
Folkman, J .
NATURE REVIEWS CANCER, 2002, 2 (10) :727-739
[9]   Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells [J].
Mertens-Talcott, SU ;
Talcott, ST ;
Percival, SS .
JOURNAL OF NUTRITION, 2003, 133 (08) :2669-2674
[10]   Analysis of ellagitannins and conjugates of ellagic acid and quercetin in raspberry fruits by LC-MSn [J].
Mullen, W ;
Yokota, T ;
Lean, MEJ ;
Crozier, A .
PHYTOCHEMISTRY, 2003, 64 (02) :617-624